Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
- Clifford J. Bailey
- , Jorge L. Gross
- , Delphine Hennicken
- , Nayyar Iqbal
- , Traci A. Mansfield
- , James F. List
- Universidade Federal do Rio Grande do Sul
- Bristol-Myers Squibb
- Bristol-Myers Squibb, Princeton
Research output: Contribution to journal › Article › peer-review
318
Link opens in a new tab
Citations
(SciVal)
207
Downloads
(Pure)